Cholangiocarcinoma - 63 Studies Found Recruiting : Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma : Cholangiocarcinoma : 2014-04-28 : Drug: CX-4945 Capsules adminis Active, not recruiting : Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma : Cholangiocarcinoma : 2015-06-24 : Procedure: Radiofrequency ablation Completed : Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib : Cholangiocarcinoma : 2006-04-28 Recruiting : A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas : Cholangiocarcinoma : 2013-05-15 : Drug: Amphinex and Gemcitabine Terminated : Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma : Cholangiocarcinoma : 2009-09-10 : Drug: WST11 WST11-mediated VTP will consist of the combination of a single IV administration of WST11 at Completed : A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma : Unresectable and Advanced Cholangiocarcinoma : 2012-10-22 : Drug: Sunitinib sunitinib dose :37.5mg/day Other Nam Recruiting : Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy : Cholangiocarcinoma : 2016-10-04 : Drug: INCB054828 INCB054828 once daily Withdrawn : Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma : Cholangiocarcinoma : 2008-07-07 : Drug: Gemcitabine, Oxaliplatin, Photodynamic therapy (Photosan®) Completed : Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma : Cholangiocarcinoma : 2006-07-10 : Drug: Gemcitabine Drug: Oxaliplatin Recruiting : A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma : Advanced Cholangiocarcinoma : 2014-05-12 : Drug: BGJ398 Capsule for oral use <<< Previous | Next >>>
